Resverlogix Advances US$30 Million Loan Closing Documentation
May 01, 2018 07:00 ET
|
Resverlogix Corp
CALGARY, Alberta, May 01, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to update the market today that it is in the final stages of closing...
Resverlogix Announces Proposed Offering of Units
April 17, 2018 09:00 ET
|
Resverlogix Corp
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, April 17, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the...
Resverlogix Announces TSX Review Update
April 12, 2018 07:00 ET
|
Resverlogix Corp
CALGARY, Alberta, April 12, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today it has received a 30-day extension to no later than May 14, 2018 for...
Resverlogix Announces US$30 Million Loan Commitment Letter
April 11, 2018 07:00 ET
|
Resverlogix Corp
CALGARY, Alberta, April 11, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is pleased to announce today that it has accepted a commitment letter for a US$30...
Resverlogix Announces Two New Publications on Apabetalone in Kidney Disease
March 28, 2018 07:00 ET
|
Resverlogix Corp
CALGARY, Alberta, March 28, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today the publication of two new articles on the effect of apabetalone, a...
Resverlogix超額完成BETonMACE第3階段關鍵臨床試驗的患者招募
March 20, 2018 01:20 ET
|
Resverlogix Corp
阿爾伯塔省卡爾加里, March 20, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp.（下文稱為「Resverlogix」或「公司」）(TSX:RVX)...
Resverlogix超额实现BETonMACE关键第3阶段临床试验的患者招募
March 20, 2018 01:20 ET
|
Resverlogix Corp
阿尔伯塔省卡尔加里, March 20, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp.（“Resverlogix”或“公司”）(TSX:RVX) 今天宣布，公司在进行中的BETonMACE第3阶段试验已经成功超额实现招募2,400名患者的计划目标，其中首例患者于2015年11月11日招募。这一试验的目标是确认Resverlogix...
Resverlogix Exceeds Full Enrollment for the Pivotal Phase 3 BETonMACE Clinical Trial
March 19, 2018 07:00 ET
|
Resverlogix Corp
CALGARY, Alberta, March 19, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has successfully surpassed the planned enrollment target of...
Resverlogix Announces Sixth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone
February 26, 2018 07:00 ET
|
Resverlogix Corp
CALGARY, Alberta, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announced that the independent Data and Safety Monitoring Board (DSMB) for the...
Resverlogix Highlights Key Accomplishments and 2018 Targets
February 08, 2018 07:00 ET
|
Resverlogix Corp
CALGARY, Alberta, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) highlighted today recent key accomplishments and 2018 targets. Recent...